BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10500580)

  • 1. The double or single renal graft depending on the percentage of glomerulosclerosis in the preimplant biopsy reduces the number of discarded kidneys from donors older than 60 years.
    Andrés A; Herrero JC; Morales E; Praga M; Vázquez S; Vereda M; Cebrián P; Rodicio JL; Morales JM; Aguirre F; Diaz R; Polo G; Leiva O
    Transplant Proc; 1999 Sep; 31(6):2285-6. PubMed ID: 10500580
    [No Abstract]   [Full Text] [Related]  

  • 2. Double versus single renal allografts from aged donors.
    Andrés A; Morales JM; Herrero JC; Praga M; Morales E; Hernández E; Ortuño T; Rodício JL; Martínez MA; Usera G; Díaz R; Polo G; Aguirre F; Leiva O
    Transplantation; 2000 May; 69(10):2060-6. PubMed ID: 10852597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded criteria donor kidneys where the paired kidney is discarded owing to biopsy results: a concept that needs revision.
    Bodzin AS; Leiby BE; Ramirez CB; Frank AM; Doria C
    Exp Clin Transplant; 2014 Dec; 12(6):499-505. PubMed ID: 25489800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of proteinuria in cyclosporine-treated cadaveric renal transplant recipients.
    Koay HC; Vathsala A; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1921-3. PubMed ID: 11120001
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute rejection episodes predict long-term renal transplantation survival.
    Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
    Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerated acute rejection in renal allograft.
    Han DJ; Yoon HS; Lee HM
    Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome of renal transplantation from elderly donors.
    Bilgin N; Karakayali H; Moray G; Demirağ A; Arslan G; Akkoç H; Turan M
    Transplant Proc; 1998 May; 30(3):744-6. PubMed ID: 9595081
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
    Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
    Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term outcome of kidney transplantation from expanded criteria donors: a single center experience.
    Golconda MS; Whiting JF; Smith R; Hayes R; Alexander JW; First MR
    Transplant Proc; 1997 Dec; 29(8):3379-81. PubMed ID: 9414756
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation.
    Cockfield SM; Moore RB; Todd G; Solez K; Gourishankar S
    Transplantation; 2010 Mar; 89(5):559-66. PubMed ID: 20110855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deceased donor organ transplantation with expanded criteria donors: a single-center experience from India.
    Goplani KR; Firoz A; Ramakrishana P; Shah PR; Gumber MR; Patel HV; Vanikar AV; Trivedi HL
    Transplant Proc; 2010; 42(1):171-4. PubMed ID: 20172307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.
    Mulloy LL; Wright F; Hall ML; Moore M
    Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome of cadaver kidneys using nonideal donors.
    Madden RL; Munda R; Hariharan S; Alexander JW; First MR
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1568-9. PubMed ID: 8442193
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
    Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
    Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
    [No Abstract]   [Full Text] [Related]  

  • 17. Cadaveric renal transplantation at University Hospital Kuala Lumpur: a preliminary report.
    Tan SY; Chen TP; Lee SH; Tan PS; Chua CT; Teo SM; Thiruventhiran T; Wo M; Loh CS; Hassan A; Tan JC; Koh SN
    Transplant Proc; 2000 Nov; 32(7):1811-2. PubMed ID: 11119947
    [No Abstract]   [Full Text] [Related]  

  • 18. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 19. Living unrelated kidney transplantation.
    Malaise J; Mourad M; Besse T; Jamar F; Baldi A; Setola P; De Meyer M; Pirson Y; Squifflet JP
    Transplant Proc; 1997 Nov; 29(7):2770-2. PubMed ID: 9365556
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome.
    Mariat C; Alamartine E; De Filippis JP; Deprele C; Le Petit JC; Goure D; Berthoux F
    Transplant Proc; 2000 Mar; 32(2):381-3. PubMed ID: 10715446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.